187 related articles for article (PubMed ID: 25175850)
1. Medication errors on oral chemotherapy in children with acute lymphoblastic leukemia in a developing country.
Oberoi S; Trehan A; Marwaha RK
Pediatr Blood Cancer; 2014 Dec; 61(12):2218-22. PubMed ID: 25175850
[TBL] [Abstract][Full Text] [Related]
2. Oral outpatient chemotherapy medication errors in children with acute lymphoblastic leukemia.
Taylor JA; Winter L; Geyer LJ; Hawkins DS
Cancer; 2006 Sep; 107(6):1400-6. PubMed ID: 16909415
[TBL] [Abstract][Full Text] [Related]
3. The circadian schedule for childhood acute lymphoblastic leukemia maintenance therapy does not influence event-free survival in the NOPHO ALL92 protocol.
Clemmensen KK; Christensen RH; Shabaneh DN; Harila-Saari A; Heyman M; Jonsson OG; Wesenberg F; Rosthøj S; Schmiegelow K;
Pediatr Blood Cancer; 2014 Apr; 61(4):653-8. PubMed ID: 24265159
[TBL] [Abstract][Full Text] [Related]
4. Oral methotrexate/6-mercaptopurine may be superior to a multidrug LSA2L2 Maintenance therapy for higher risk childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study.
Schmiegelow K; Heyman M; Kristinsson J; Mogensen UB; Rosthøj S; Vettenranta K; Wesenberg F; Saarinen-Pihkala U;
J Pediatr Hematol Oncol; 2009 Jun; 31(6):385-92. PubMed ID: 19648786
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetically based dosing of thiopurines in childhood acute lymphoblastic leukemia: influence on cure rates and risk of second cancer.
Levinsen M; Rotevatn EØ; Rosthøj S; Nersting J; Abrahamsson J; Appell ML; Bergan S; Bechensteen AG; Harila-Saari A; Heyman M; Jonsson OG; Maxild JB; Niemi M; Söderhäll S; Schmiegelow K;
Pediatr Blood Cancer; 2014 May; 61(5):797-802. PubMed ID: 24395436
[TBL] [Abstract][Full Text] [Related]
6. [Leukemia and malnutrition. II. The magnitude of maintenance chemotherapy as a prognostic factor in the survival of patients with standard-risk acute lymphoblastic leukemia].
Lobato-Mendizábal E; Ruiz-Argüelles GJ
Rev Invest Clin; 1990; 42(2):81-7. PubMed ID: 2267453
[TBL] [Abstract][Full Text] [Related]
7. Nutritional state alterations in children with acute lymphoblastic leukemia during induction and consolidation of chemotherapy.
Mejía-Arangure JM; Fajardo-Gutíerrez A; Bernáldez-Ríos R; Rodríguez-Zepeda MC; Espinoza-Hernández L; Martínez-García MC
Arch Med Res; 1997; 28(2):273-9. PubMed ID: 9204621
[TBL] [Abstract][Full Text] [Related]
8. Maintenance chemotherapy of acute lymphoblastic leukemia in children.
Schmiegelow K
Dan Med Bull; 1998 Nov; 45(5):510-32. PubMed ID: 9850812
[No Abstract] [Full Text] [Related]
9. Poor treatment compliance in children with down syndrome and acute lymphoblastic leukemia.
Bohnstedt C; Taskinen M; Zeller B; Björgvinsdóttir H; Hafsteinsdottir S; Schmiegelow K
J Pediatr Hematol Oncol; 2009 Jan; 31(1):79-80. PubMed ID: 19125098
[No Abstract] [Full Text] [Related]
10. Patients' Adherence in the Maintenance Therapy of Children and Adolescents with Acute Lymphoblastic Leukemia.
Kremeike K; Juergens C; Alz H; Reinhardt D
Klin Padiatr; 2015 Nov; 227(6-7):329-34. PubMed ID: 26457956
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of central nervous system relapse of pediatric acute lymphoblastic leukemia: Impact of routine cytological CSF analysis at the time of intrathecal chemotherapy.
Gassas A; Krueger J; Alvi S; Sung L; Hitzler J; Lieberman L
Pediatr Blood Cancer; 2014 Dec; 61(12):2215-7. PubMed ID: 25212396
[TBL] [Abstract][Full Text] [Related]
12. Value of intravenous 6-mercaptopurine during continuation treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma: final results of a randomized phase III trial (58881) of the EORTC CLG.
van der Werff Ten Bosch J; Suciu S; Thyss A; Bertrand Y; Norton L; Mazingue F; Uyttebroeck A; Lutz P; Robert A; Boutard P; Ferster A; Plouvier E; Maes P; Munzer M; Plantaz D; Dresse MF; Philippet P; Sirvent N; Waterkeyn C; Vilmer E; Philippe N; Otten J
Leukemia; 2005 May; 19(5):721-6. PubMed ID: 15744348
[TBL] [Abstract][Full Text] [Related]
13. Systemic exposure to mercaptopurine as a prognostic factor in acute lymphocytic leukemia in children.
Koren G; Ferrazini G; Sulh H; Langevin AM; Kapelushnik J; Klein J; Giesbrecht E; Soldin S; Greenberg M
N Engl J Med; 1990 Jul; 323(1):17-21. PubMed ID: 2355954
[TBL] [Abstract][Full Text] [Related]
14. Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia.
Evans WE; Relling MV; Rodman JH; Crom WR; Boyett JM; Pui CH
N Engl J Med; 1998 Feb; 338(8):499-505. PubMed ID: 9468466
[TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus retinitis as an adverse immunological effect of pulses of vincristine and dexamethasone in maintenance therapy for childhood acute lymphoblastic leukemia.
Moritake H; Kamimura S; Kojima H; Shimonodan H; Harada M; Sugimoto T; Nao-I N; Nunoi H
Pediatr Blood Cancer; 2013 Feb; 60(2):329-31. PubMed ID: 22976937
[TBL] [Abstract][Full Text] [Related]
16. The association between fasting hypoglycemia and methylated mercaptopurine metabolites in children with acute lymphoblastic leukemia.
Melachuri S; Gandrud L; Bostrom B
Pediatr Blood Cancer; 2014 Jun; 61(6):1003-6. PubMed ID: 24415675
[TBL] [Abstract][Full Text] [Related]
17. Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: a Childrens Cancer Group study.
Lange BJ; Blatt J; Sather HN; Meadows AT
Med Pediatr Oncol; 1996 Jul; 27(1):15-20. PubMed ID: 8614385
[TBL] [Abstract][Full Text] [Related]
18. Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997-2004).
Veerman AJ; Kamps WA; van den Berg H; van den Berg E; Bökkerink JP; Bruin MC; van den Heuvel-Eibrink MM; Korbijn CM; Korthof ET; van der Pal K; Stijnen T; van Weel Sipman MH; van Weerden JF; van Wering ER; van der Does-van den Berg A;
Lancet Oncol; 2009 Oct; 10(10):957-66. PubMed ID: 19747876
[TBL] [Abstract][Full Text] [Related]
19. Fasting hypoglycemia is common during maintenance therapy for childhood acute lymphoblastic leukemia.
Halonen P; Salo MK; Mäkipernaa A
J Pediatr; 2001 Mar; 138(3):428-31. PubMed ID: 11241057
[TBL] [Abstract][Full Text] [Related]
20. Outcome of acute lymphoblastic leukemia in children with AL90 regimen: impact of response to treatment and sex difference on prognostic factors.
Ishii E; Eguchi H; Matsuzaki A; Koga H; Yanai F; Kuroda H; Kawakami K; Ayukawa H; Akiyoshi K; Kamizono J; Tamai Y; Kinukawa N; Okamura J
Med Pediatr Oncol; 2001 Jul; 37(1):10-9. PubMed ID: 11466717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]